POSC22 Demographics and Clinical DATA of a Real World Cohort of Multiple Sclerosis Patients Being Treated with Interferon Beta-1A SC in Portugal

To present initial Real World Evidence (RWE) from a patient support program registry of patients with multiple sclerosis currently being treated with interferon beta-1a s.c. in Portugal.

Source: Value in Health - January 1, 2022 Category: International Medicine & Public Health Authors: M Ribeiro, D Leal Source Type: research